Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients.
Okamoto J; Kratz JR; Hirata T; Mikami I; Raz D; Segal M; Chen Z; Zhou HM; Pham P; Li H; Yagui-Beltran A; Ray MR; Koizumi K; Shimizu K; Jablons D; He B; Clinical Lung Cancer, 2011, vol. 12, issue 4, p 237, ISSN 19380690. ISBN 19380690.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef